Table 3 Outcomes
Variable | Result |
|---|---|
Postoperative outcomes | Mean (SD) |
In-Hospital stay | 5.2 (4.5) |
% (n) | |
|---|---|
Mortality | 0% (0) |
Morbidity | 26.6 (12) |
Re-admission | 6.6 (3) |
Clavien Dindo | |
Type 0 | 73.3 (33) |
Type 1 | 4.4 (2) |
Type 2 | 10 (22.2) |
Pathology analysis | |
Hyperplasia | 4.4 (2) |
Adenoma | 42.2 (19) |
Pheocromocytoma | 17.78 (8) |
Myelolipoma | 4.4 (2) |
Cyst | 2.2 (1) |
Metastases | 4.4 (2) |
Cortical Hyperplasia | 13.3 (6) |
Ganglioneuroma | 2.2 (1) |
Normal Adrenal Gland | 2.2 (1) |
Bronchogenic cyst | 2.2 (1) |
Medular Hyperplasia | 2.2 (1) |
Neoplasm | 2.2 (1) |
Drug ussage | Mean (SD) |
|---|---|
Pre-operative | 1.8 (1.2) |
Postoperative | 0.73 (0.96) |
Change (AHC) | 1.06 (1.1) |